Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present DarioHealth Corp. (NASDAQ: DRIO).

Full DD Report for DRIO

You must become a subscriber to view this report.


Recent News from (NASDAQ: DRIO)

DarioHealth Corp. 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by DarioHealth Corp. in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: May, 16 2018 14:04
DarioHealth's (DRIO) CEO Erez Raphael on Q1 2018 Results - Earnings Call Transcript
DarioHealth Corp. (DRIO) Q1 2018 Results Earnings Conference Call May 15, 2018, 9:00 AM ET Executives Erez Raphael - Chief Executive Officer Zvi Ben-David - Chief Financial Officer Analysts Steve Wardell - Chardan Capital Markets Mark Lanier - Pegasus Capital Jeff Silver ...
Source: SeekingAlpha
Date: May, 15 2018 14:44
DarioHealth misses by $0.01, beats on revenue
DarioHealth (NASDAQ: DRIO ): Q1 EPS of -$0.20 misses by $0.01 . Revenue of $1.76M (+74% Y/Y)   beats by $0.02M . Press Release More news on: DarioHealth Corp., Earnings news and commentary, Tech stocks news, ,
Source: SeekingAlpha
Date: May, 15 2018 08:03
DarioHealth Reports First Quarter 2018 Results
NEW YORK and CAESAREA, Israel , May 15, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported financial and operational results for the first quarter ended on March 31, 2018 . First...
Source: PR Newswire
Date: May, 15 2018 08:00
DarioHealth Releases Next Generation Version 4.0 of its Award-Winning App
NEW YORK and CAESAREA, Israel , May 8, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced the availability of its award-winning next-generation app, version 4.0. The upgraded user...
Source: PR Newswire
Date: May, 08 2018 08:00
DarioHealth to Host First Quarter 2018 Conference Call on May 15, 2018
NEW YORK and CAESAREA, Israel , May 2, 2018 /PRNewswire/ --  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will release its first quarter 2018 results on Tuesday, May 15th and host a co...
Source: PR Newswire
Date: May, 02 2018 08:00
DarioHealth Ramps up Commercialization Capabilities
NEW YORK and CAESAREA, Israel , April 30, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has hired U.S.-based digital health executive JC Muyl as Head of Commercialization North...
Source: PR Newswire
Date: April, 30 2018 08:00
DarioHealth, New Glucose Monitoring System, Climbing Revenue, and Analysts Target
NEW YORK, NY / ACCESSWIRE / April 4, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report with no obligation on DarioHealth Corp. (NASDAQ: DRIO), a global digital health c...
Source: ACCESSWIRE IA
Date: April, 04 2018 08:05
DarioHealth Launches Customer Hotline to Pre-Order Its Apple iPhone Lightning-Compatible Glucose Monitor in the U.S.
NEW YORK and CAESAREA, Israel , March 29, 2018 /PRNewswire/ --  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced it will offer its past and current subscription holders the option to pre-order its f...
Source: PR Newswire
Date: March, 29 2018 08:30
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of DarioHealth Corp.
Levi & Korsinsky announces it has commenced an investigation of DarioHealth Corp. (NASDAQCM: DRIO) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/DRIO-Info-Request-Form-6565 or contact Joseph E. Levi, Esq. eithe...
Source: Business Wire
Date: March, 27 2018 10:02

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-171.051.061.09591.0116,608
2018-08-161.061.05551.09091.0221,770
2018-08-151.161.111.161.0940,749
2018-08-141.151.171.191.1316,660
2018-08-131.201.161.331.0662,887

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-173,4238,90038.4607Short
2018-08-1652619,9082.6422Cover
2018-08-155,39116,22133.2347Cover
2018-08-147,51711,75863.9309Short
2018-08-136,20018,45133.6025Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on DRIO.


About DarioHealth Corp. (NASDAQ: DRIO)

Logo for DarioHealth Corp. (NASDAQ: DRIO)

We are a mobile health mHealth company developing and commercializing patented technology providing consumers with laboratory testing capabilities using smart phones and other mobile devices. We were formed in August as a Delaware corporation. Our initial product is Dario TM , a mobile, cloud based, diabetes management solution which includes novel software applications combined with a stylish, all in one , pocket sized, blood glucose monitoring device which we call our Dario TM Smart Meter that will compete in the estimated billion dollar worldwide market for patient self monitoring of blood glucose which we refer to as SMBG products. Dario TM is a comprehensive system incorporating patented technology that combines a cutting edge software application and cloud based data services with a novel all in one Dario TM Smart Meter consisting of a lancet to obtain a blood sample , a device specific disposable test strip cartridge and a smartphone driven glucose reader adaptor.

 

 

 

Current Management

  • Erez Raphael / President, CEO
  • Zvi BenDavid / CFO, Secretary, Treasurer
  • Ronen Raviv / Corporate Controller
  • Erez Raphael / Chairman
  • Dr. Malcolm Hoenliein /
  • Hila Karah /
  • Dennis M McGrath / Director
    • Dennis M. McGrath was appointed to our Board in July . He served as our President and Chief Financial Officer from January until May , he previously was CEO and President from July through December , and CFO and Vice President, finance and administration from January through June . From February to January , he served as COO of Internet Practice, the largest division for AnswerThink Consulting Group, Inc. and from August until January , as CFO of Think New Ideas, Inc. He was responsible for the merger integration of Think New Ideas and AnswerThink. He was CFO and executive vicepresident, operations of TriSpan, Inc. from September to February , an internet commerce solutions and technology consulting company acquired by AnswerThink in . Mr. McGrath is currently a director of Noninvasive Medical Technologies, Inc., Dario Health, Inc. formerly LabStyle, Inc. and Cagent Vascular, Inc. and serves on the Board of Trustees for Manor College and the Board of Visitors for Taylor University. He is currently CFO of PAVMed, Inc. Mr. McGrath graduated with a B.S. in accounting from LaSalle University in and became a Certified Public Accountant in and holds inactive licenses in Pennsylvania and New Jersey.
  • Richard Stone /
  • Rami Yehudiha /

Current Share Structure

  • Market Cap: $21,420,324 - 03/16/2018
  • Authorized: 160,000,000 - 03/01/2018
  • Issue and Outstanding: 14,185,645 - 03/01/2018

 


Recent Filings from (NASDAQ: DRIO)

Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: May, 16 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Simplified registration form
Filing Type: S-3Filing Source: edgar
Filing Date: April, 26 2018
Simplified registration form
Filing Type: S-3Filing Source: edgar
Filing Date: April, 26 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 12 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 02 2018
Proxy soliciting materials. Revised preliminary material
Filing Type: PRER14AFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 02 2018
Proxy soliciting materials. Revised preliminary material
Filing Type: PRER14AFiling Source: edgar
Filing Date: April, 02 2018

 

 


Daily Technical Chart for (NASDAQ: DRIO)

Daily Technical Chart for (NASDAQ: DRIO)


Stay tuned for daily updates and more on (NASDAQ: DRIO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: DRIO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in DRIO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of DRIO and does not buy, sell, or trade any shares of DRIO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/